Rheumatology Trials Seem Vulnerable to Unblinding: Report

Until more is known about the potential for unblinding, clinicians need to keep in mind that patients and physicians could often guess accurately who was getting placebo or active drug.
MDedge News

source https://www.medscape.com/s/viewarticle/rheumatology-trials-unblinding-seem-vulnerable-2023a1000k1w?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?